Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

8.3%

1 terminated/withdrawn out of 12 trials

Success Rate

90.0%

+3.5% vs industry average

Late-Stage Pipeline

33%

4 trials in Phase 3/4

Results Transparency

11%

1 of 9 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 4

4(36.4%)

N/A

3(27.3%)

Phase 1

2(18.2%)

Phase 2

2(18.2%)

11Total

Phase 4(4)

N/A(3)

Phase 1(2)

Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials

NCT05284877Recruiting

The Organ Transplant Recipient HPV and Skin Cancer Study

Role: lead

NCT05202860Phase 2Active Not Recruiting

Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients with Actinic Keratosis

Role: lead

NCT05937529Not ApplicableCompleted

Impact of Madecassoside and 5 % Panthenol Cream in Post Photodynamic Therapy for Actinic Keratosis

Role: lead

NCT05461755Phase 2Completed

Treatment of Striae Distensae With Fractional Radiofrequency and Topical Tretinoin

Role: lead

NCT05057117Phase 4Completed

Longevity of Microwave Thermolysis and Botulinum Toxin A for Treatment of Axillary Hyperhidrosis

Role: lead

NCT03541252Phase 1Completed

Topical Laser-assisted Combination Chemotherapy for Basal Cell Carcinoma- a Clinical Study

Role: lead

NCT03573115Not ApplicableCompleted

Multimodal Optical Imaging for Pretreatment Evaluation for Cutaneous Microparticle Delivery

Role: lead

NCT03573076Phase 4Terminated

Treatment of Photodamaged Skin of the décolleté

Role: lead

NCT04221126Phase 4Completed

TMFI Enhances Skin Surface and Epidermal PpIX Fluorescence

Role: lead

NCT03569345Phase 1Completed

Basal Cell Carcinomas Treated With Ablative Fractional Laser and Ingenol Mebutate

Role: lead

NCT03524040Not ApplicableCompleted

Imaging of Pilosebaceous Units and Acne Lesions by RCM and OCT Confocal Microscopy and Optical Coherence Tomography

Role: lead

NCT02761174Phase 4Completed

Topical Brimonidine to Reduce Inflammation After IPL-treatment in Patients With Facial Telangiectasias

Role: lead

All 12 trials loaded